Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
BioArctic: Lecanemab Receives Priority Review Status in Japan
BioArctic AB’s partner Eisai has announced that the application for manufacturing and marketing approval for […]
Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication
Ascletis Pharma announces that the China National Medical Products Administration (NMPA) has approved the Investigational […]
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease
BioArctic AB‘s partner Eisai have announced that the European Medicines Agency (EMA) has accepted a […]
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline […]
Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products
Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid and lipid nanoparticle […]
Daewoong Pharmaceutical Submitted NDA for its Global New Drug Fexuclue in 11 Countries
Fexuclue from Daewoong Pharmaceutical is attracting attention as a game changer in the global gastroesophageal […]
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
POXEL SA, a clinical-stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic […]
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight's Enzymatic doggybone DNA Technology
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a […]
Modus Therapeutics Submits Patent Application for Sevuparin in Kidney Disease
Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet medical […]
French Biotech Company AdipoPharma Secures Funding for Groundbreaking Diabetes Drug
AdipoPharma, a French biotech company developing a novel and promising type 2 diabetes drug, has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more